In the realm of modern medicine, peptides and semaglutide have gained significant attention as potential game-changers in weight management
The share who report ever taking these drugs rises to four in ten (43%) among adults who have been told by a doctor that they have diabetes, a quarter who have been told they have heart disease, and one in five (22%) who have been told by a doctor that they are overweight or obese in the past five years 1
[2] [3] However, there is a plausible connection between Rybelsus and this symptom based on the drug's mechanism of action and known gastrointestinal side effects
As you age the levels of this powerful antioxidant in your body and cells fall and it is further depleted by stress, infection, illness, and exercise
With insulin, there is risk of weight gain, for hypoglycemia, and theres more treatment burden and need for glucose monitoring. GLP-1 drugs have also been shown to have cardiovascular benefits, she adds, though further clinical trials are needed to assess orforgliprons effects on heart health